📰 Although Merck News
Although Merck News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Although Merck. Real-time updates on events, politics, business and more.
May 1, 2024
Merck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates.
November 6, 2021
Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and the United Kingdom became the first country to OK it this week.
November 5, 2021
Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and the United Kingdom became the first country to OK it this week.
November 5, 2021
Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and the United Kingdom became the first country to OK it this week.
November 5, 2021
Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and the United Kingdom became the first country to OK it this week.
November 5, 2021
Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and the United Kingdom became the first country to OK it this week.
November 5, 2021
Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and the United Kingdom became the first country to OK it this week.
November 5, 2021
Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and the United Kingdom became the first country to OK it this week.
November 5, 2021
Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and the United Kingdom became the first country to OK it this week.
November 5, 2021
Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and the United Kingdom became the first country to OK it this week.